The role of butyric acid and inulin in enhancing the efficiency and tolerability of eradication therapy

DOI: https://doi.org/10.29296/25877305-2019-05-07
Download full text PDF
Issue: 
5
Year: 
2019

T. Sviridova(1), N. Alekseev(1), I. Olkhovik(2), A. Astakhova(3) 1-N.N. Burdenko Voronezh State Medical University 2-Voronezh City Clinical Emergency Hospital Ten 3-Voronezh City Clinical Polyclinic Seven

The paper presents the results of studying the efficacy and tolerability of standard triple eradication therapy for Helicobacter pylori infection when using Zakofalk®, a combined drug containing butyric acid and inulin.

Keywords: 
gastroenterology
Helicobacter pylori
eradication therapy
prebiotics
inulin
butyric acid



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Malfertheiner R. et al. Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus Report // Gut. – 2016; 0: 1–25. DOI: 10.1136/gutjnl-2016-312288.
  2. Ivashkin V.T., Maev I.V. i dr. Klinicheskie rekomendatsii Rossijskoj gastroenterologicheskoj assotsiatsii po diagnostike i lecheniju infektsii Helicobacter pylori u vzroslyh // RZhGGK. – 2018; 28 (1): 55–70 [Ivashkin V.T., Mayev I.V. et al. Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association // Ross. Z. Gastroenterol. Gepatol. Koloproktol. – 2018; 28 (1): 55–70 (in Russ.)]. DOI: 10.22416/1382-4376-2018-28-1-55-70.
  3. Maev I.V., Kucherjavyj Ju.A., Andreev D.N. Prichiny neeffektivnosti antigelikobakternoj terapii // RZhGGK. – 2013; 6: 62–72 [Mayev I.V., Kucheryavy Yu.A., Andreyev D.N. The causes for inefficacy of antihelicobacter therapy // Ross. Z. Gastroenterol. Gepatol. Koloproktol. – 2013; 6: 62–72 (in Russ.)].
  4. Graham D., Lew G., Malaty H. et al. Factors influencing the eradication of Helicobacter pylori with triple therapy // Gastroenterology. – 1992; 102: 493–6.
  5. Hudson N., Brydon W., Eastwood M. et al. Successful H. pylori eradication incorporating a one-week antibiotic regimen // Aliment. Pharmacol. Ther. – 1995; 9: 47–50.
  6. Peura D., Crowe S. Helicobacter pylori. Sleisenger & Fordtran’s gastrointestinal and liver disease. Eds. M. Feldman, L. Friedman, L. Brandt. 9th ed. / Philadelphia, Pa: Saunders Elsevier, 2010.
  7. Nista E. Effect of butyric acid and inulin supplementation on side effects of anti-Hp therapy: preliminary data. Presentation at DDW 2006, 2006.
  8. Butorova L.I., Plavnik T.A., Kadnikova N.G. i dr. Znachenie disbioticheskih narushenij tolstoj kishki v patogeneze Helicobacter pylori-assotsiirovannyh zabolevanij gastroduodenal'noj zony. Rol' prebiotikov v povyshenii effektivnosti antihelikobakternoj terapii // Lechaschij vrach. – 2013; 3: 92–6 [Butorova L.I., Plavnik T.A., Kadnikova N.G. et al. Meaning of dysbiotic disorders of large intestine in pathogenesis of gastroduodenal zone diseases associated with Helicobacter pylori. Meaning of prebiotics in increase of anti-helicobacter therapy efficiency // Lechashchii vrach. – 2013; 3: 92–6 (in Russ.)].
  9. Durleshter V.M., Korochanskaja N.V., Popandopulo K.I. i dr. Sovremennye podhody k hirurgicheskomu i medikamentoznomu lecheniju jazv zheludka: uchebno-metodicheskoe posobie / Krasnodar, 2017 [Durleshter V.M., Korochanskaya N.V., Popandopulo K.I. et al. Sovremennye podkhody k khirurgicheskomu i medikamentoznomu lecheniyu yazv zheludka: uchebno-metodicheskoe posobie / Krasnodar, 2017 (in Russ.)].
  10. Avalueva E., Skazyvaeva E., Bakulin I. i dr. Povyshenie komplaentnosti pri eradikatsionnoj terapii hronicheskogo Hp-assotsiirovannogo gastrita // Vrach. – 2018; 29 (12): 9–14 [Avalueva E., Skazyvaeva E., Bakulin I. et al. Increasing compliance in the eradication therapy of chronic Hp-associated gastritis // Vrach. – 2018; 29 (12): 9–14 (in Russ.)]. https://doi.org/10.29296/25877305-2018-12-02.
  11. Shul'pekova Ju.O. Antibiotikoassotsiirovannaja diareja // RMZh. – 2007; 6: 467 [Shul’pekova Yu.O. Antibiotikoassotsiirovannaya diareya // RMZh. – 2007; 6: 467 (in Russ.)].
  12. Ford A., Gurusamy K., Delaney B. et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people // Cochrane Database Syst. Rev. – 2016; 4: CD003840.
  13. Lin Li et al. The Effect of Helicobacter pylori Eradication on the Gastrointestinal Microbiota in Patients with Duodenal Ulcer // J. Gastrointestin. Liver Dis. – 2016; 25 (2): 139–46.
  14. Izumi Shimbo et al. Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy // World J. Gastroenterol. – 2005; 11 (47): 7520–4.
  15. Golovenko O.V., Halif I.L., Golovenko A.O. Rol' masljanoj kisloty v lechenii organicheskih i funktsional'nyh zabolevanij tolstoj kishki // Klin. perspektivy gastroenterol. i gepatol. – 2011; 3: 20–9 [Golovenko O.V., Khalif I.L., Golovenko A.O. Role of butyric acid in the treatment of patients with organic and functional bowel diseases (Review of the literature)// Klin. perspektivy gastroenterol. i gepatol. – 2011; 3: 20–9 (in Russ.)].
  16. Mordasova V.I., Sviridova T.N., Fursova E.A. Effektivnost' primenenija preparata Zakofal'k pri luchevyh porazhenijah tolstoj kishki // Prikladnye informatsionnye aspekty meditsiny. – 2016; 19 (3): 91–5 [Mordasova V.I., Sviridova T.N., Fursova E.A. Effektivnost’ primeneniya preparata Zakofal’k pri luchevykh porazheniyakh tolstoi kishki // Prikladnye informatsionnye aspekty meditsiny. – 2016; 19 (3): 91–5 (in Russ.)].
  17. Opyt primenenija preparata Zakofal'k v razlichnyh oblastjah gastroenterologii: sb. nauch.-prakt. rabot. Pod red. M.D. Ardatskoj / M.: Art, 2013; 64 s. [Opyt primeneniya preparata Zakofal’k v razlichnykh oblastyakh gastroenterologii: sb. nauch.-prakt. rabot. Pod red. M.D. Ardatskoi / M.: Art, 2013; 64 s. (in Russ.)].
  18. Uspenskij Ju.P., Suvorov A.N., Baryshnikova N.V. Infektsija Helicobacter pylori v klinicheskoj praktike / SPb: InformMed, 2011; 572 s. [Uspenskii Yu.P., Suvorov A.N., Baryshnikova N.V. Infektsiya Helicobacter pylori v klinicheskoi praktike / SPb: InformMed, 2011; 572 s. (in Russ.)].
  19. Sitkin S.I., Vahitov T.Ja., Tkachenko E.I. i dr. Disbioz kishechnika pri jazvennom kolite i tseliakii i ego terapevticheskaja korrektsija s pomosch'ju masljanoj kisloty v kombinatsii s inulinom // Eksperim. i klin. gastroenterol. – 2017; 142 (6): 77–98 [Sitkin S.I., Vakhitov T.Ya., Tkachenko E.I. et al. Dysbiosis in ulcerative colitis and celiac disease and its therapeutic correction by butyric acid plus inulin // Eksperimental’naya i Klinicheskaya Gastroenterologiya 2017; 142 (6): 77–98 (in Russ.)].
  20. Zaharenko S.M. Povyshenie effektivnosti antibiotikoterapii / M.: Prima Print, 2018; 130 s. [Zakharenko S.M. Povyshenie effektivnosti antibiotikoterapii / M.: Prima Print, 2018; 130 s. (in Russ.)].